Robert Wessman
BOARD OF DIRECTORS
Cancer
LOTUS
Japan
Biography
Robert Wessman became the Executive Chairman of Alvogen in July 2009 and is now Chairman & CEO of the group. Since founding the business 6 years ago, Robert has grown Alvogen from a small US business into a glabal pharmaceutical with commercial operations in 35 countries and with 2,500 employees. Under his leadership, Alvogen has set a clear goal to become a top five global generics player, and is making strong progress towards that ambition. Wessman’s vision to create an organisation which is able to respond to the needs of its customers has led to the development of a balanced yet specialised portfolio consisting of 500 marketed products, as well as a deep pipeline of high-value products in development.
Research Interest
Cancer
